MAPT and Cognitive impairment: For example, monoclonal antibodies against p-tau217 have been found to reduce tau aggregation, block apoptosis-associated neuronal loss, decrease brain atrophy, reverse cognitive deficits, and improve motor function in tauopathic mice [40].